A volunteer involved in AstraZeneca and Oxford University’s coronavirus vaccine trial has died, Brazilian health authority Anvisa announced on Wednesday, according to Reuters. It was not immediately clear if the man received the vaccine or had been part of a placebo group. An anonymous source told Reuters that if the victim had received the vaccine, the trial would have been stopped. An AstraZeneca spokesperson told Fox News that the company cannot comment on individual cases in an ongoing trial due to regulations. STUDY SUGGESTS MOST VULNERABLEIn June, Brazil announced a deal to purchase 100 million doses of the potential coronavirus vaccine should it prove to be safe and effective.

Source: Fox News October 21, 2020 19:43 UTC